Menu
Clinical Evidence Library
Category: Company News
VivaQuant, a digital health company providing remote cardiac arrhythmia monitoring services under its Rhythm Express brand, is pleased to announce
St. Paul, Minnesota, August 2023 VivaQuant, a digital health company providing remote cardiac arrhythmia monitoring services under its Rhythm Express
VivaQuant is not anything like the dozen or so Minnesota businesses that have sought funding directly from small investors in
VivaQuant selected as a finalist for the Tekne Medical Technology innovation award for its unique wearable arrhythmia monitor.
VivaQuant, a digital health company with powerful technology to accurately and efficiently identify and report cardiac arrhythmias, has received FDA
This study demonstrates that fully automated continuous beat to beat measurements over 24 hours can be obtained using the Rhythm
VivaQuant has entered into a five-year collaboration with the FDA to research ways to improve cardiac safety assessment of medications.
VivaQuant MDSP technology was the subject of a recent manuscript published in The Journal of Pharmacological and Toxicological Methods (JPTM)
Fully automated QT measurements, obtained from VivaQuant Rhythm Express software, with no human review or editing, were shown to improve
Arrangement allows researchers to use the unique VivaQuant algorithms on ECG signals acquired by DSI telemetry and wired acquisition technologies.